e-learning
resources
Vienna 2012
Tuesday, 04.09.2012
Molecular biology of pro- and anti-inflammatory responses in the lung
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Targeting miRNA-based medicines to cystic fibrosis airway epithelial cells using nanotechnology
P. J. McKiernan, O. Cunningham, N. G. McElvaney, S. A. Cryan, C. M. Greene (Dublin, Ireland)
Source:
Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung
Session:
Molecular biology of pro- and anti-inflammatory responses in the lung
Session type:
Thematic Poster Session
Number:
3723
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. J. McKiernan, O. Cunningham, N. G. McElvaney, S. A. Cryan, C. M. Greene (Dublin, Ireland). Targeting miRNA-based medicines to cystic fibrosis airway epithelial cells using nanotechnology. Eur Respir J 2012; 40: Suppl. 56, 3723
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Related content which might interest you:
Novel antiviral properties of azithromycin in cystic fibrosis airway epithelial cells
Source: Eur Respir J 2015; 45: 428-439
Year: 2015
CFTR targeted therapies: recent advances in cystic fibrosis and possibilities in other diseases of the airways
Source: Eur Respir Rev, 29 (156) 190068; 10.1183/16000617.0068-2019
Year: 2020
Proteomics characterisation of nasal epithelial cells in cystic fibrosis
Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Year: 2009
Targeting aENaC with an epithelial RNAi trigger delivery platform for the treatment of cystic fibrosis
Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments
Year: 2018
Investigation of the status of cystic fibrosis airway epithelial cells
Source: Annual Congress 2008 - Multigenic expression analyses: a guide for diagnosis and therapy
Year: 2008
Hypoxia and sterile inflammation in cystic fibrosis airways: mechanisms and potential therapies
Source: Eur Respir J 2017; 49(1): 1600903; DOI: 10.1183/13993003.00903-2016
Year: 2017
Novel therapeutics for cystic fibrosis
Source: ERS Webinar 2020: Novel therapeutics for cystic fibrosis
Year: 2020
Potential therapeutic use of 12-Lipoxygenase inhibitors in the treatment of mucus overproduction in cystic fibrosis
Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease
Year: 2009
Treatment of cystic fibrosis airway cells with CFTR modulators reverses aberrant mucus properties
via
hydration
Source: Eur Respir J, 59 (2) 2100185; 10.1183/13993003.00185-2021
Year: 2022
Novel antiviral properties of vitamin D in cystic fibrosis airway epithelial cells
Source: International Congress 2014 – Cystic fibrosis: assessment and treatment
Year: 2014
Epithelial cell regulation of immunity in cystic fibrosis
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new basic and clinical physiology research
Year: 2012
Correction of CFTR function in intestinal organoids to guide treatment of cystic fibrosis
Source: Eur Respir J, 57 (1) 1902426; 10.1183/13993003.02426-2019
Year: 2021
Modeling the regenerative potential of airway epithelial cells
Source: Virtual Congress 2020 – (Re-)discovering the small airway epithelium in COVID-19, fibrosing lung diseases and pulmonary regeneration
Year: 2020
microRNA-mediated inhibition of IL-8 production from cystic fibrosis bronchial epithelial cells
Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science
Year: 2013
Targeting CFTR as a therapy for cystic fibrosis
Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung
Year: 2010
Towards personalized medicine in idiopathic pulmonary fibrosis by screening exhaled volatiles in patients’ primary bronchial epithelial cells
Source: Virtual Congress 2020 – Cellular stress in respiratory diseases
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept